CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung

Lung Cancer

Volumn 57, Issue 1, 2007, Pages 46-53

  Kwon, Mi Seon ^a   Shin, Seung Hun ^b   Yim, Seon Hee ^c   Lee, Kyo Young ^b   Kang, Hyun Mi ^b   Kim, Tae Min ^b   Chung, Yeun Jun ^b  

^a Dankook University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

CD63; Immunohistochemistry; Non small cell lung cancer; Real time qRT PCR; Tissue microarray; Transmembrane 4 superfamily

Indexed keywords

BIOLOGICAL MARKER; CD63 ANTIGEN; RNA;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TISSUE MICROARRAY;

ADENOCARCINOMA; AGED; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; PLATELET MEMBRANE GLYCOPROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 34249701754     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.01.032     Document Type: Article

References (29)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
2. In: Travis W.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon 9-44
3. Huber R.M., and Stratakis D.F. Molecular oncology-perspectives in lung cancer. Lung Cancer 45 suppl 2 (2004) S209-S213
4. Maecker H.T., Todd S.C., and Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J 11 (1997) 428-442
5. Hunziker W., and Geuze H.J. Intracellular trafficking of lysosomal membrane proteins. Bioessays 18 (1996) 379-389
6. Atkinson B., Ernst C.S., Ghrist B.F., Herlyn M., Blaszczyk M., Ross A.H., et al. Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res 44 (1984) 2577-2581
7. Wright M.D., and Tomlinson M.G. The ins and outs of the transmembrane 4 superfamily. Immunol Today 15 (1994) 588-594
8. Kobayashi T., Vischer U.M., Rosnoblet C., Lebrand C., Lindsay M., Parton R.G., et al. The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11 (2000) 1829-1843
9. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266 (1991) 21327-21330
10. Griffiths G.M. Secretory lysosomes-a special mechanism of regulated secretion in haemopoietic cells. Trends Cell Biol 6 (1996) 329-332
11. Kobayashi T., Beuchat M.H., Lindsay M., Frias S., Palmiter R.D., Sakuraba H., et al. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1 (1999) 113-118
12. Longo N., Yanez-Mo M., Mittelbrunn M., de la Rosa G., Munoz M.L., Sanchez-Madrid F., et al. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 98 (2001) 3717-3726
13. Huang C.I., Kohno N., Ogawa E., Adachi M., Taki T., and Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153 (1998) 973-983
14. Sho M., Adachi M., Taki T., Hashida H., Konishi T., Huang C.L., et al. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79 (1998) 509-516
15. Owens D.M., and Watt F.M. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Res 61 (2001) 5248-5254
16. Gesierich S., Paret C., Hildebrand D., Weitz J., Zgraggen K., Schmitz-Winnenthal F.H., et al. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 11 (2005) 2840-2852
17. Adachi M., Taki T., Konishi T., Huang C.I., Higashiyama M., and Miyake M. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 16 (1998) 1397-1406
18. Miyake M., Adachi M., Huang C., Higashiyama M., Kodama K., and Taki T. A novel molecular staging protocol for non-small cell lung cancer. Oncogene 18 (1999) 2397-2404
19. Tokuhara T., Hasegawa H., Hattori N., Ishida H., Taki T., Tachibana S., et al. Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res 7 (2001) 4109-4114
20. Adachi M., Taki T., Ieki Y., Huang C.L., Higashiyama M., and Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56 (1996) 1751-1755
21. Higashiyama M., Doi O., Kodama K., Yokouchi H., Adachi M., Huang C.L., et al. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 74 (1997) 205-211
22. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DeltaDeltaC(T)) method. Methods 25 (2001) 402-408
23. Jang H.I., and Lee H. A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells. Exp Mol Med 35 (2003) 317-323
24. Radford K.J., Thorne R.F., and Hersey P. Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158 (1997) 3353-3358
25. Chen Z., Mustafa T., Trojanowicz B., Brauckhoff M., Gimm O., Schmutzler C., et al. CD82, and CD63 in thyroid cancer. Int J Mol Med 14 (2004) 517-527
26. Sikora L.K., Pinto A., Demetrick D.J., Dixon W.T., Urbanski S.J., Temple W., et al. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes. Int J Cancer 39 (1987) 138-145
27. Li J., Li W., Liang S., Cai D., Kieny M.P., Jacob L., et al. Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic mice. J Immunol 171 (2003) 2922-2929
28. Hotta H., Ross A.H., Huebner K., Isobe M., Wendeborn S., Chao M.V., et al. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 48 (1988) 2955-2962
29. Funakoshi T., Tachibana I., Hoshida Y., Kimura H., Takeda Y., Kijima T., et al. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene 22 (2003) 674-687